Skip to main content
search

Preclinical

Sign up

Latest resources

Featured resource

Upcoming preclinical webinars

Latest preclinical blogs

Meet our experts at the following events

Conference

KIC Korea 2026

October 13 - 15, 2026 – Seoul, Korea
Conference

EANM 2026

October 17 - 21, 2026 – Vienna, Austria
Conference

AAPS 2026 PharmSci 360

October 25 - 28, 2026

All preclinical resources

Strategy Starts at Discovery: Using QSP to Choose the Right Indication, the Right Asset, and the Right Path to First-in-Human

Biologics, Certara Services, Drug Development, Modeling and Simulation - QSP, On-Demand Webinar

Drug-Drug Interaction (DDI) Calculator

Drug Development, Drug-Drug Interactions (DDI), Model Informed Drug Development, Fact Sheet

From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development

Modeling and Simulation - QSP, Publication

Securing Pimicotinib Approval: How Abbisko Therapeutics Successfully Completed its NMPA and FDA Submissions with Pinnacle 21 Enterprise

Certara Products - Pinnacle 21, Case Study

Get the Presentation: Building Investor-Ready Biotech Strategies

Drug Development, Drug Development Support, Guide

Enable AI to Access your PK Data: What’s New in Integral 7.1

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

From Prediction to Decision Making: PBPK and QSP as Regulatory-Grade NAMs

Certara Products - Certara IQ, Certara Products - Simcyp, Infectious Disease, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Oncology/Hematology, Publication

Modeling effective doses of therapeutic antibodies targeting clustered surface receptors

Biologics, Certara Services, Immuno-oncology, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Publication

Model-Informed Strategies for ADC Development

ADC, Biologics, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, White Paper

When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing

Certara Services, Drug Development, Model Informed Drug Development, Oncology, Pharmacometrics, Publication

External Data Accelerator: Your standards-first team and technology for conformant vendor data

Certara Products - Pinnacle 21, Certara Services, Data Standards, Fact Sheet

Pharmacometrics Approach Group in Japan 2026​

Modeling and Simulation - PBPK, Modeling and Simulation - QSP, Conference
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.